Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GLG1 Antikörper

GLG1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN1589833
  • Target Alle GLG1 Antikörper anzeigen
    GLG1 (Golgi Glycoprotein 1 (GLG1))
    Reaktivität
    • 41
    • 13
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 23
    • 16
    • 2
    Kaninchen
    Klonalität
    • 24
    • 17
    Polyklonal
    Konjugat
    • 21
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser GLG1 Antikörper ist unkonjugiert
    Applikation
    • 32
    • 19
    • 14
    • 14
    • 13
    • 11
    • 11
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB)
    Verwendungszweck
    ESL-1 antibody
    Spezifität
    Recombinant human soluble ESL-1
    Aufreinigung
    Protein A purified
    Immunogen
    Recombinant human soluble ESL-1
    Isotyp
    IgG
    Top Product
    Discover our top product GLG1 Primärantikörper
  • Applikationshinweise
    Western Blot: Use 1-5 μg/mL
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
    Buffer
    PBS
    Handhabung
    Centrifuge vial prior to opening.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
    Haltbarkeit
    24 months
  • Target
    GLG1 (Golgi Glycoprotein 1 (GLG1))
    Andere Bezeichnung
    ESL-1 (GLG1 Produkte)
    Synonyme
    AI593353 antikoerper, AW537898 antikoerper, CFR antikoerper, CFR-1 antikoerper, ESL-1 antikoerper, MG-160 antikoerper, MG160 antikoerper, Selel antikoerper, ESL1 antikoerper, LTCP-1 antikoerper, golgi glycoprotein 1 antikoerper, Golgi apparatus protein 1 antikoerper, golgi apparatus protein 1 antikoerper, GLG1 antikoerper, LOC100175586 antikoerper, Glg1 antikoerper
    Hintergrund
    Golgi apparatus protein-1, E-selectin ligand-1, Cysteine-rich fibroblast growth factor receptor,E-Selectin ligand-1/ESL-1 (GLG1, Golgi complex-Localized Glycoprotein 1, CFR1, MG160 and Cysteine-rich FGF receptor) is a 150-160 kDa glycoprotein. The amino acid sequence of MG160, a membrane sialoglycoprotein of the medial cisternae of the rat Golgi apparatus, is more than 90 % identical with CFR, a fibroblast growth factor (FGF) binding protein of chicken membranes, and with ESL-1, a ligand for E-selectin of plasma membranes of myeloid cells, furthermore, MG160, isolated by immunoaffinity chromatography from rat brain membranes, binds to basic FGF. The protein has a large luminal domain composed of an initial Proline-Glutamine-rich segment, encoded by an uninterrupted exonic sequence of several CAG-CAA repeats. Expansion of CAG repeats has been implicated in the etiology of several neurodegenerative diseases. The Proline-Glutamine-rich segment is followed by 16 cysteine-rich repeats that contain five potential Asparagine-linked glycosylation sites, which are conserved in the human, rat, mouse, and chicken. The large extracellular domain of the protein is followed by a single transmembrane domain and a 13-amino-acid cytoplasmic carboxy-terminal tail, which is identical to that in the chicken, rat, and mouse. It is expressed in both Golgi and/or the cell membrane of multiple cell typs, including liver stellate cells, neurons, cardiac myocytes, monocytes and bronchial epithelial cells. In the blood, GLG1/ESL-1 collaborates with PSGL-1 to mediate leukocyte binding to endothelial cell surfaces
    Gen-ID
    2734
    NCBI Accession
    NM_001145666, NP_001139138
    UniProt
    Q92896
Sie sind hier:
Kundenservice